Inga Petersen
Forskare vid Institutionen för farmaci; Biologiska läkemedel; ProDDe
- E-post:
- inga.petersen@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Publikationer
Senaste publikationer
-
Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Ingår i Frontiers in Pharmacology, 2025
- DOI för Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
- Ladda ner fulltext (pdf) av Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
-
Ingår i Scientific Reports, 2024
- DOI för A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Ladda ner fulltext (pdf) av A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
Ingår i mAbs, 2023
- DOI för Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
- Ladda ner fulltext (pdf) av Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
Alla publikationer
Artiklar i tidskrift
-
Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
Ingår i Frontiers in Pharmacology, 2025
- DOI för Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
- Ladda ner fulltext (pdf) av Enhancing therapeutic antibody profiling: orthogonal strategies for stability and quality assessment
-
Ingår i Scientific Reports, 2024
- DOI för A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Ladda ner fulltext (pdf) av A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
Ingår i mAbs, 2023
- DOI för Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
- Ladda ner fulltext (pdf) av Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates